Luspatercept, 25 mg, 75 mg Suppliers & Bulk Manufacturers
Available Forms: Lyophilized powder for subcutaneous injection
Available Strengths: 25 mg, 75 mg
Reference Brands: Reblozyl
Category: Anemia
Luspatercept (Reblozyl) is an FDA and EMA-approved biologic used to treat anemia in beta thalassemia and MDS patients. It reduces transfusion needs by enhancing red blood cell production. Offered in GMP-certified form, ideal for pharma B2B buyers, distributors, and exporters. Contact us for bulk supply and regulatory support.
Product Description:
Luspatercept is a groundbreaking erythroid maturation agent used to treat anemia in patients with beta thalassemia and myelodysplastic syndromes (MDS). Marketed under the brand name Reblozyl, it is approved by the FDA and EMA for reducing red blood cell transfusion dependence. Luspatercept is a recombinant fusion protein administered via subcutaneous injection and produced under strict GMP compliance. Ideal for pharmaceutical distributors, wholesalers, and B2B partners seeking high-demand biologics. We offer global bulk supply, regulatory support, and competitive pricing for Luspatercept. Partner with us for reliable sourcing and efficient delivery. Contact us now for Luspatercept export and distribution solutions.
Luspatercept, — third party manufacturing & bulk supply
Luspatercept, 25 mg, 75 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Luspatercept, is supplied as Lyophilized powder for subcutaneous injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Luspatercept, listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Luspatercept, →Frequently Asked Questions
Luspatercept is used to treat anaemia in adults with beta-thalassemia who require regular red blood cell transfusions. It is also used in certain patients with myelodysplastic syndromes (MDS) to reduce the need for blood transfusions.
It is made from a recombinant fusion protein that binds to specific TGF-beta superfamily ligands, helping enhance late-stage red blood cell maturation in the bone marrow.
The trade name is Reblozyl.
Luspatercept (Reblozyl) is manufactured by Bristol Myers Squibb in collaboration with Acceleron Pharma.
The generic name is Luspatercept-aamt.
The brand name is Reblozyl.
It is manufactured in the United States and other approved Bristol Myers Squibb production sites globally.
Related Products
Eltrombopag Tablet
Strength:
Tablet: 12.5 mg, 25 mg, 50 mg, 75 mg; Suspension:25 mg per packet
Form: Oral Tablets & Oral Powder for Oral Suspension
Reference Brands: Promacta,Revolade
View Details
Crizanlizumab
Strength:
100 mg/10 mL (10 mg/mL)
Form: IV Infusion
Reference Brands: Adakveo®(EU & US)
View Details
Hydroxyurea
Strength:
Capsules: 200 mg, 300 mg, 400 mg, 500 mg; Tablets: 100 mg, 500 mg, 1,000 mg
Form: Capsules and Tablets
Reference Brands: Hydrea, Droxia , Siklos
View Details
Elemental Iron, Multivitamin Capsule
Strength:
Elemental Iron: 14 mg - 65 mg
Form: Capsule
Reference Brands: Slow Fe®, Feosol® Complete, Ferrochel®, Irontab®, Feroglobin®, Feroglobin®, SiderAL®
View Details
Iron(Iii)-Isomaltoside Injection
Strength:
100mg/ml
Form: Injection
Reference Brands: Monofer,, Diafer, Monoferric
View Details
Deferasirox
Strength:
125 mg, 250 mg, 500 mg
Form: Tablets for Oral Suspension
Reference Brands: Exjade, Jadenu (film-coated)
View Details
Deferoxamine
Strength:
500 mg/vial, 2 g/vial
Form: Lyophilized powder for injection
Reference Brands: Desferal
View Details
Ferumoxytol Injection
Strength:
30 mg/mL
Form: Injection
Reference Brands: Feraheme (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
